[Methergin therapy of secretory conditions after hysterectomy].
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008755:Methylergonovine; D010120:Oxytocics; D011247:Pregnancy; D014599:Uterus / Q000601:surgery*
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics; D008755:Methylergonovine
ERGOT ALKALOIDS/therapeutic use; UTERUS/surgery
Methergin zur Behandlung von Sekretverhaltungen nach Uterusexstirpation.